September 21, 2021
Michael J. Moore, a professor of biomedical engineering at Tulane University School of Science and Engineering, is part of a national study that aims to turn statistics on opioid addiction around by creating a living bioengineered nerve circuit that mimics the pain transmission pathway in the spinal cord.
August 25, 2021
Tulane researcher Michael Naguib has led a team in discoveries that could result in significantly faster charging electric vehicles and portable devices such as cell phones and laptops.
August 24, 2021
Dr. Pedro Barata, assistant professor of medicine in the Department of Hematology and Medical Oncology, led a retrospective study to find racial differences in the molecular characterization of advanced prostate tumors using liquid biopsies.
August 17, 2021
A new Tulane University study finds that cycle thresholds (Ct) from PCR tests — an indicator of the amount of virus an infected person carries — aren’t a reliable gauge for identifying those most likely to transmit COVID-19.
August 05, 2021
Tulane University researchers have developed a new type of blood test to find COVID-19 infections that may be missed by nasal swab PCR tests. The blood test uses nanoparticles to detect fragments of the virus released by infected cells anywhere in the body according to new study published in the journal Nature Nanotechnology.
July 26, 2021
Jesse M. Keenan, an associate professor of real estate in the Tulane School of Architecture is co-editor of the new book COVID-19: Systemic Risk and Resilience (Springer, 2021), which features 22 chapters were written by experts from around the world who have assisted their home countries in managing the COVID-19 crisis.
July 21, 2021
Tulane researcher Kristin Miller is teaming up with the Tulane spin-out company BioAesthetics Corp. to develop a new graft for treating pelvic organ prolapse (POP).
July 21, 2021
Tulane University School of Medicine and Children’s Hospital New Orleans are participating in a national clinical trial to test the effectiveness of Moderna’s COVID-19 vaccine in children ages six months to 11 years old.
July 14, 2021
Key infectious disease researchers at Tulane University, Duke University and North Carolina State University will collaborate on an initiative to develop a treatment for bartonelloses, a spectrum of vector-borne diseases that can cause debilitating symptoms. The three-year, $4.8 million initiative funded by The Steven and Alexandra Cohen Foundation, will establish the Bartonella Research Consortium to develop a novel treatment for bartonelloses.
July 12, 2021
Michael J. Moore, a professor of biomedical engineering at Tulane, will lead an NIH group that reviews applications on a wide range of technologies as applied to neural systems and to tissues of the eye.
June 20, 2021
Tulane's Commitment to Equity Institute has received almost $1.2 million from the Bill & Melinda Gates Foundation to assess how the COVID-19 pandemic and resulting fiscal policies have affected inequality, poverty and mobility.